ߜ The authors prospectively investigated cerebral hemodynamic changes in 152 patients with head injuries to clarify the relationship between cerebral vasospasm and outcome. They also sought to determine the most clinically meaningful criteria for diagnosing cerebral vasospasm. Patients with varying degrees of moderate-to-severe head injury were monitored using transcranial Doppler (TCD) ultrasonography and intravenous , respectively, divided by the hemispheric or global CBF). The authors investigated the clinical significance of elevated flow velocity, hemispheric ratio, and spasm index. Patients diagnosed as having MCA or BA vasospasm on the basis of TCD-derived criteria alone had a significantly worse outcome than patients without vasospasm. When CBF was considered, hemodynamically significant vasospasm, as defined by an elevated spasm index, was even more strongly associated with poor outcome. Stepwise logistic regression analysis confirmed that hemodynamically significant vasospasm was a significant predictor of poor outcome, independent of the effects of admission Glasgow Coma Scale score and age. On the basis of the results of this study, the authors suggest that the important factor impacting on outcome is not vasospasm per se, but hemodynamically significant vasospasm with low CBF. These findings show that vasospasm is a pathophysiologically important posttraumatic secondary insult, which is best diagnosed by the combined use of TCD and CBF measurements. 
EREBRAL arterial spasm (vasospasm) was first demonstrated using cerebral angiography and has long been known to occur after head injury. 30, 48, 52 The findings of early angiographic studies indicated an important role for posttraumatic vasospasm in determining outcome by reporting an association between angiographically demonstrated vasospasm and neurological deterioration 30, 52 as well as noncontusion related infarct. 7, 28, 30 The detrimental effects of vasospasm are presumably related to impaired cerebral blood flow (CBF), as indicated by the slowing of the circulation and poor filling seen on angiograms in patients with vasospasm. 30, 48 Following its introduction in 1982, transcranial Doppler (TCD) ultrasonography has largely superseded angiography as a convenient technique for detecting vasospasm of the large basal cerebral arteries. [1] [2] [3] 7, 10, 17, 24, 33, 34, 36, 44, 47, 50, 53 Transcranial Doppler ultrasonography is noninvasive and particularly well suited for serial monitoring, which are valuable qualities because vasospasm that occurs after traumatic brain injury appears to be a delayed phenomenon, 11, 33, 34, 44, 47, 50, 53 as is the case after aneurysmal subarachnoid hemorrhage (SAH). 51 Numerous previous TCD investigations have failed to demonstrate convincingly an independent, statistically significant association between posttraumatic vasospasm and outcome; 10, 12, 34, 44, 47, 50 however, part of the problem has been the absence of any large prospective studies. The primary purpose of our current study was to investigate in a prospective manner the relationship between posttraumatic cerebral vasospasm and outcome in a large sample population.
It appears that the disadvantages of the various TCDderived diagnostic criteria have contributed to the problem of defining the relationship between vasospasm and outcome. The TCD criteria for diagnosing cerebral vasospasm have undergone an evolution of sorts since the introduction of the technique. Early studies simply used threshold flow velocities (for example, a middle cerebral artery [MCA] velocity greater than 120 cm/second) to de-fine vasospasm. 1, 10 Elevated flow velocity, however, can result from elevated CBF or changes in perfusion territory, as well as from arterial narrowing. 7, 34, 46 In 1989, Lindegaard, et al., 27 demonstrated a substantial agreement between angiographic vasospasm and a ratio, defined as the mean MCA velocity (V MCA ) divided by the ipsilateral extracranial internal carotid artery (EC-ICA) velocity (V EC-ICA ), resulting in a number greater than 3. This V MCA /V EC-ICA ratio, or hemispheric ratio (HR; also known as the "Lindegaard ratio"), was found to correlate better with angiographic findings than the absolute V MCA alone and was also much less influenced by the patient's age. 27 Because the EC-ICA is not narrowed by SAH-induced vasospasm, a linear relationship between V EC-ICA and CBF is assumed and the HR is presumed to help compensate for alterations in CBF. It has been shown, however, that the ICA diameter can vary widely with gender and skull size. 16 The variation in ICA diameter within the population makes it difficult to define clinically meaningful diagnostic criteria for vasospasm using the HR. In a study of patients with SAH, Jakobsen, et al., 21 avoided some of these problems by quantitatively measuring regional CBF in the MCA territory, specifically the initial slope index (ISI), with the 133 Xe inhalation technique. These CBF data were then used with absolute V MCA to calculate a "spasm index" (SI) defined as V MCA /CBF ISI . Although their study population was small, their results suggested a relationship between SI and outcome, with all patients having a peak SI lower than 3.1 demonstrating good recovery. 21 Furthermore, the SI was found to be inversely related to CBF and directly related to the arteriovenous difference in oxygen (AVDO 2 ), indicating that elevations in the SI reflected pathologically significant hemodynamic changes. 21 To relate our current study to previous reports, we have investigated these various diagnostic parameters to determine their relative value in predicting outcome.
The current report is a follow up to preliminary results already published. 33 We used TCD ultrasonography and intravenous 133 Xe regional CBF studies to investigate in a prospective manner cerebral hemodynamic changes in 152 patients with head injuries. Our main goal was to clarify the relationship between posttraumatic cerebral vasospasm and outcome, with a secondary goal of determining the most relevant criteria for diagnosing clinically significant cerebral vasospasm.
Clinical Material and Methods

Patient Population
In a prospective longitudinal cohort study, we evaluated 152 patients with traumatic brain injuries (139 with closed head injuries and 13 with penetrating head injuries) admitted to the Harbor-University of California at Los Angeles (UCLA) and UCLA Medical Centers between July 1992 and December 1994. These patients were selected from a larger cohort of 274 patients who were admitted during the same time period and recruited for enrollment in the clinical head trauma investigation at the UCLA Brain Injury Research Center; all research protocols were reviewed and approved by the UCLA and Harbor-UCLA Human Research Committees. Inclusion criteria for the current study consisted of patient consent to, and enrollment in, the Brain Injury Research Center protocol; patient having undergone at least one TCD recording or 133 Xe-CBF measurement during the hospital stay; and patient outcome being evaluated at 6 months postinjury. Twenty-eight female and 124 male patients were included in this study; their ages ranged from 16 to 80 years with a mean of 33.5 years (standard deviation 15.6 years). Postresuscitation admission Glasgow Coma Scale 49 (admGCS) scores ranged from 3 to 15 with a median admGCS score of 7. There were no statistically significant differences in age, gender ratio, or admGCS score between the larger recruited cohort and the enrolled study population.
General Management Protocol
After the initial computerized tomography scan or surgery, patients were admitted directly to the intensive care unit. All received routine intensive care management, which, when clinically indicated, included: intracranial pressure (ICP) monitoring, central venous catheter placement, arterial pressure monitoring, electroencephalography, and mechanical ventilation. Sedatives, vasopressors (such as dopamine and levophed), mannitol, barbiturates, albumin, and blood products were administered as necessary. Nimodipine was not routinely administered to patients in this study. Among the 152 patients in the present study, only two men (one, aged 37 years, with an admGCS score of 6, and the other, aged 54 years, with an admGCS score of 13) were given nimodipine. Both had good recovery at 6 months.
Twenty patients were concurrently enrolled in the completed United States/Canadian study of tirilazad mesylate in the treatment of moderate and severe head injury, 32 which is similar in design to a recently completed international study. Only 10 patients actually received tirilazad (10 mg/kg/day), whereas 10 received vehicle only. Compared with patients receiving vehicle only and with patients in the entire study group, the 10 tirilazad-treated patients were demographically similar, demonstrating no significant difference in age, admGCS score, or gender ratio (p Ͼ 0.1 for all comparisons). Furthermore, this small tirilazad-treated group did not display a significantly different incidence of vasospasm (whether defined by TCD criteria or SIs; p Ͼ 0.1) or poor outcome (40% for tirilazad-treated patients versus 40% in the vehicle group and 34% in the entire study group; p = 0.72 and 0.76, respectively). Because the patients who received tirilazad did not appear to represent a significant confounding factor, they were retained in the present analysis.
Cerebral Hemodynamic Monitoring
The head injury management protocol at the Harbor-UCLA and UCLA Medical Centers includes intensive cerebral hemodynamic monitoring. Both TCD studies and 133 Xe-CBF measurements were performed at the patient's bedside as soon as possible after admission and repeated regularly according to the Brain Injury Research Center research protocol, or as indicated clinically, until the patient died, recovered, or was transferred or discharged. Significant abnormalities in TCD flow velocities or CBF, with or without changes in neurological findings, prompted a careful assessment of relevant physiological parameters (such as arterial blood pressure, arterial blood gas lev-els, ICP, hemoglobin, and hematocrit). Abnormalities in these parameters were corrected to optimize cerebral perfusion (for example, using cerebrospinal fluid drainage to decrease ICP or vasopressors to maintain cerebral perfusion pressure at Ն 70 mm Hg); however, no specific treatment (a course of nimodipine, hypervolemic hemodilutional hypertensive therapy, or angioplasty) was administered for TCD-diagnosed vasospasm.
Transcranial Doppler Ultrasonography
Recordings were made of the mean blood flow velocity in the MCA, EC-ICA, and basilar artery using a 2-MHz probe. These vessels were insonated through temporal (MCA), submandibular (EC-ICA), and suboccipital/ foraminal (basilar artery [BA] ) windows according to the general principles first described by Aaslid, et al. 3 All measurements were performed with the aid of a commercially available TCD apparatus (Neuroguard Cerebrovascular Diagnostic System; Nicolet Biomedical, Inc., Madison, WI). Mean velocity recordings from this instrument represent the mean velocity averaged over four cycles. Pertinent physiological parameters (such as arterial blood pressure, ICP, and hematocrit) were recorded, when available, during all studies.
Initial TCD studies were generally performed within 24 to 48 hours after admission. Serial studies were performed at regular intervals for the first 2 weeks after admission, and thereafter when clinically indicated. Patients who had TCD evidence of vasospasm (see Definitions of Terms and Table 1 
Cerebral Blood Flow Measurements
Cerebral blood flow measurements were performed at the patient's bedside using the intravenous 133 Xe clearance technique previously described. 4, 20, 34, [38] [39] [40] Approximately 20 to 30 mCi of gaseous xenon-133 dissolved in saline was injected intravenously for each study. Cerebral clearance curves were recorded over 11 minutes from 10 extracranial sodium iodide detectors, five of which were located over the approximate MCA territory in each hemisphere. Analytic computer software was then used to extrapolate the data to 15 minutes, referencing the cerebral clearance curves to the clearance curve of exhaled end-tidal xenon-133 (used to estimate the arterial concentration of xenon-133). A two-compartment, modified height-over-area method 40 was then used to calculate the hemispheric CBF 15 (CBF 15-H , calculated from five detectors on one side) and global CBF 15 (CBF 15-G , calculated from all 10 detectors). The CBF 15 represents the mean flow of both fast-and slow-clearing compartments and is insensitive to "slippage," more stable than single compartment parameters (such as F1) in pathological conditions, and has been used extensively in head trauma investigations. 13, 20, [38] [39] [40] Pertinent physiological parameters (for instance, blood pressure, ICP, arterial blood gas levels, and hematocrit) were recorded during each study. 15-G ).
Clinical Outcome
A Glasgow Outcome Scale (GOS) 22 score was determined for all 152 patients approximately 6 months after injury. Outcome has been shown to stabilize after 6 months and this time span appears to be an appropriate end point for clinical studies in head injury. 9 Scores were determined on the basis of interviews with patients or their families, questioning of rehabilitation therapists involved in patients' extended care, or analyzing discharge reports from rehabilitation facilities. Patients were assigned to one of five categories: death, persistent vegetative state, severe disability, moderate disability, or good recovery. Patients were considered to have achieved a "good" outcome if they were assigned to the moderate disability or good recovery categories, and a "poor" outcome if they died or were assigned to the persistent vegetative state or severe disability groups.
Definitions of Terms
High Mean MCA Velocity. In 1984, Aaslid, et al., 1 report- ) greater than 3, and between severe angiographic vasospasm and an HR greater than 6. The same threshold values are used in this current report to define, respectively, "high" and "very high" HRs.
Transcranial Doppler-Diagnosed MCA Vasospasm. Previous studies by Martin and colleagues 33, 34 have required both a threshold MCA velocity of 120 cm/second and an HR of greater than 3 to diagnose MCA vasospasm using TCD ultrasonography alone. The use of the HR in combination with an absolute V MCA aids in differentiating between elevated velocities that are secondary to elevated CBF and those that are elevated primarily as a result of vasospasm. These criteria are used in the current report to define TCD-diagnosed MCA vasospasm.
Transcranial Doppler-Diagnosed BA Vasospasm. Sloan, et al., 45 reported 100% specificity but only 39% sensitivity for the diagnosis of angiographically confirmed BA vasospasm when the BA threshold velocity was 95 cm/ second. In the current report, a threshold velocity of 90 cm/second is used to define TCD-diagnosed BA vasospasm to maintain a high degree of specificity (93% as reported by Sloan, et al.) while presumably improving sensitivity.
Cerebral Blood Flow. In 1984, Obrist and associates If the normal range is defined as the mean Ϯ 2 standard deviations, then the normal range is approximately 33 to 55 ml/100 g/minute. In this current report, low CBF is generally defined as a CBF 15 of 35 ml/100 g/minute or less and absolute hyperemia as a CBF 15 of more than 55 ml/100 g/minute.
Middle Cerebral Artery SI. In 1990, Jakobsen, et al., 21 reported using a unitless SI in patients with SAH. ). One difficulty with this index is that the CBF 15-G does not specifically represent the CBF in the posterior circulation, which is not directly quantitated by our technique for CBF measurement. Studies using the stable Xe-CT technique in head-injured patients have shown, however, that the CBF in posterior fossa structures is quantitatively similar to that in the cerebral hemispheres (that is, cerebral hemorrhagic oligemia or hyperemia is generally accompanied by cerebellar/ brainstem oligemia or hyperemia). 6, 29 We therefore believe that CBF 15-G is the most reasonable substitute available. We defined the threshold for high BA SI as the quotient derived by dividing our threshold value for high V BA (90 cm/second) by our threshold for low CBF (35 ml/100 g/minute); that is, approximately 2.5.
Statistical Analysis
For correlation with GOS score at 6 months, we used the nonparametric Spearman correlation analysis. Significant differences between groups for continuous variables (such as age, CBF, and flow velocities) were determined using a two-tailed t-test for independent samples. Significant differences between groups for nonparametric variables (such as GOS score and admGCS score) were determined using the Mann-Whitney U-test. Comparisons between ratios (for example, gender ratios and incidence of low CBF) were performed using chi-square 
Results
Correlation of Clinical and Hemodynamic Variables With Outcome
We performed Spearman correlation analysis to determine which parameters, among the eight tested, had the best correlation with GOS score at 6 months ( Table 2) . Highly significant or significant correlations were demonstrated for the following variables (listed in descending order of the absolute Spearman r): admGCS score, lowest CBF, highest BA SI, highest MCA SI, and highest HR. 
Clinical and Hemodynamic Differences Between Good and Poor Outcome Groups
To determine which parameters varied most significantly between good and poor outcome groups, we calculated the mean or median values of eight variables in the two outcome groups (Table 3) . Highly significant differences between good and poor outcome groups were found for admGCS scores and the highest BA SI, whereas significant differences were demonstrated for lowest CBF and age. The difference in the mean highest MCA SI between good and poor outcome groups represents a statistical trend. No statistically significant difference was found for highest V MCA , V BA , or HR between good and poor outcome groups. In addition, there was no significant difference in gender between good and poor outcome groups (p Ͼ 0.1; data not shown).
Middle Cerebral Artery Vasospasm and Outcome
We evaluated the relationship between MCA vasospasm and outcome (Table 4 ). The MCA vasospasm was defined in four ways by means of criteria that are currently in clinical use and have been used in previous studies: Table 4 ). There was no significant difference in outcome between the groups of patients with unilateral and bilateral MCA vasospasm (p = 0.5). Similarly, there was no significant difference in outcome between the 22 patients who developed both MCA and BA vasospasm and the 38 who developed MCA vasospasm alone (p = 0.29).
Middle Cerebral Artery Vasospasm Diagnosed by MCA Spasm Index: Combined Use of MCA Velocity and Hemispheric CBF. Thirty-three (39%) of 85 patients had at least one MCA SI greater than 3.4 (high MCA SI group); 52 patients (61%) never had an MCA SI exceed 3.4 (normal MCA SI group). The worse outcome associated with the high MCA SI group was highly significant (p = 0.006; Fig. 1 upper and Table 4 ).
Basilar Artery Vasospasm and Outcome
We evaluated the relationship between BA vasospasm and outcome (Table 4) Table 4 ).
Basilar Artery Vasospasm Diagnosed by BA SI: Combined
Use of BA Velocity and Global CBF. Among 70 patients with at least one calculated BA SI, 13 (19%) had at least one BA SI greater than 2.5 (high BA SI group) and 57 (81%) never had a BA SI exceed 2.5 (normal BA SI group). The worse outcome associated with patients in the high BA SI group was highly significant (p = 0.0023; Fig.  1 lower and Table 4 ).
Cerebral Blood Flow and Outcome
We evaluated the relationship between CBF and outcome (Table 4) . Among 91 patients in whom CBF was measured, 58 (64%) had at least one measurement of 35 ml/100 g/minute or lower (low CBF group), whereas 33 (36%) maintained CBF above 35 ml/100 g/minute (normal-high CBF group). Patients in the low CBF group had a significantly worse outcome (p = 0.021).
Relationships Among Flow Velocity, CBF, and Outcome
To determine the importance of considering CBF when interpreting elevated flow velocities, we investigated the incidence of elevated V CBF (p = 0.29, Fig. 2 ). Although a greater percentage of patients with both elevated V MCA and low CBF had a poor outcome compared with those with elevated velocity and normal/high CBF (50% vs. 44%), this difference did not reach statistical significance (p = 0.53).
Relationship Between SI and CBF
To elucidate the relationship between elevated SIs and CBF, we compared the incidence of low CBF among patients with elevated and normal SIs. Among 33 patients with a high MCA SI, 28 (85%) had simultaneously low ipsilateral CBF 15-H . In contrast, only 22 (42%) of 52 patients with a normal MCA SI had low CBF (Fig. 3) . Twelve (92%) of 13 patients with a high BA SI had simultaneously low CBF 15-G . Twenty-six (46%) of 57 patients who did not have a high BA SI developed low CBF 15-G . The higher incidence of low CBF among patients with high MCA and BA SIs compared with those with normal MCA and BA SIs was highly significant (p = 0.0001 and p = 0.0037, respectively).
Associations Among TCD-Diagnosed Vasospasm, Hemodynamically Significant Vasospasm, and CBF
Middle Cerebral Artery Vasospasm. There were 42 patients with TCD-diagnosed MCA vasospasm who also had a calculated MCA SI. Among these 42 patients, 27 (64%) developed hemodynamically significant vasospasm as defined by at least one high MCA SI (MCA vasospasm/high SI group). Twenty-two (81%) of the 27 patients had hemodynamically significant vasospasm with low CBF, whereas five maintained normal CBF. Fifteen (56%) of the 27 patients with hemodynamically significant vasospasm had poor outcome. There were 15 patients (36%) among the 42 with TCD-diagnosed vasospasm who did not have a high MCA SI (and, therefore, did not develop hemodynamically significant vasospasm [MCA vasospasm/normal SI group]). Only four (27%) of those 15 patients had a poor outcome. Outcome for patients in the MCA vasospasm/high SI group was significantly worse compared with that for the MCA vasospasm/normal SI group (p = 0.011; Fig. 4 ). Basilar Artery Vasospasm. Among 18 patients who had BA vasospasm according to TCD criteria and at least one calculated BA SI, 11 (61%) developed hemodynamically significant vasospasm as defined by at least one BA SI greater than 2.5 (BA vasospasm/high SI group). Ten (91%) of these 11 patients had hemodynamically significant vasospasm with low CBF 15-G and only one maintained normal CBF. Eight (73%) of the 11 patients with hemodynamically significant vasospasm had poor outcome. There were seven patients (39%) among the 18 with TCD-diagnosed BA vasospasm who did not have a BA SI greater than 2.5 and, by definition, did not develop hemodynamically significant vasospasm (BA vasospasm/normal SI group). Three (43%) of those seven patients had poor outcomes. Although the BA vasospasm/high SI group had a higher percentage of patients with poor outcome compared with the BA vasospasm/normal SI group (73% vs. 43%, respectively), this difference did not reach statistical significance (p = 0.26).
Relationship of Age, AdmGCS, and Gender to TCD and CBF Measurements
Age of Patient. The influence of age on TCD and CBF measurements was assessed ( Table 4 ). The lower mean age of patients with at least one mean V MCA of 120 cm/second or greater compared with those without an elevated V MCA was highly significant (p = 0.0055). Similarly, the lower mean age for patients with TCD-diagnosed MCA vasospasm compared with that for patients without MCA vasospasm was highly significant (p = 0.0067). Patients with TCD-diagnosed BA vasospasm demonstrated a trend toward younger age than those not diagnosed with BA vasospasm (p = 0.082). In contrast, low CBF was associated with a significantly higher mean age than normalhigh CBF (p = 0.015). There were no significant differences in mean age between high and normal groups for HR, MCA SI and BA SI (p = 0.37, p = 0.79, and p = 0.6, respectively).
Admission GCS Score. The association between admGCS score and subsequent TCD and CBF measurements was assessed. The lower median admGCS score among groups of patients with high V MCA , TCD-diagnosed MCA vasospasm, TCD-diagnosed BA vasospasm, very high HR, high HR, low CBF, high MCA SI, and high BA SI compared with groups of patients without high V MCA , without TCD-diagnosed MCA or BA vasospasm, with normal HR, normal-high CBF, normal MCA SI, and normal BA SI was highly significant (p Ͻ 0.01 for all comparisons).
Gender. The influence of gender on TCD and CBF measurements was assessed. There were no significant differences in the gender ratio between any of the groups compared (p Ͼ 0.1 for all comparisons).
Stepwise Logistic Regression Analysis for Outcome at 6 Months
A stepwise logistic regression analysis was performed to test whether the influence of a high MCA or BA SI on outcome was independent of the influence of admGCS score and age (Table 5) .
Middle Cerebral Artery SI, AdmGCS Score, and Age.
Stepwise logistic regression analysis of all 85 patients with at least one calculated MCA SI (admGCS score of 3-15) demonstrated that admGCS scores had the strongest independent influence on outcome (p = 0.0024), followed by age (p = 0.0069). The MCA SI approached, but did not achieve, a statistical trend toward an independent contribution to poor outcome when all patients were included in FIG. 3 . Graph showing the incidence of low CBF in patients with and without a high (Ͼ 3.4) MCA SI. An elevated MCA SI appears to represent vasospasm severe enough to impair CBF, that is, hemodynamically significant vasospasm. The probability value was calculated from the chi-square analysis of incidence. For the high MCA SI group, only low CBF that occurred simultaneously with the high MCA SI is depicted.
FIG. 4. Graph showing the difference in outcome between
patients with TCD-diagnosed vasospasm with at least one high MCA SI and patients with TCD-diagnosed MCA vasospasm without a high MCA SI. The important factor impacting on outcome appears to be hemodynamically significant vasospasm, as defined by an elevated MCA SI rather than TCD-diagnosed vasospasm. The probability value in the graph was calculated from a MannWhitney U analysis of outcome between the two groups. Age is given as the mean Ϯ standard deviation, whereas admGCS score is given as the median and range; probability values for differences in mean age and median admGCS score are provided. Poor outcome is defined as death, persistent vegetative state, or severe disability; good outcome as moderate disability or good recovery. the analysis (p = 0.1; Table 5 ). Stratification of patients by admGCS scores, however, revealed the following: 1) the MCA SI was shown to have a statistically significant independent influence on outcome when patients with the most severe injuries (admGCS scores of 3 or 4) were excluded (p = 0.072 for patients with admGCS scores of 4-15; p = 0.047 for admGCS scores of 5-15, Table 5 ; p = 0.047 for admGCS scores of 6-15); 2) conversely, age exhibited a significant independent contribution to outcome only when patients with the most severe injuries (admGCS scores of 3-5) were included (p = 0.08 for patients with admGCS scores of 6-15; p = 0.032 for admGCS scores of 5-15; p = 0.025 for admGCS scores of 4-15); and 3) analysis of 24 patients with very severe injuries (admGCS scores of 3-5) confirmed a significant contribution to outcome by age (p = 0.023) with no statistically significant independent contribution by MCA SI (p = 0.72).
Basilar Artery SI, AdmGCS Score, and Age.
Stepwise logistic regression analysis of all 70 patients (admGCS scores of 3-15) with at least one calculated BA SI revealed a highly significant contribution to outcome by admGCS score (p = 0.0012) and age (p = 0.0074) with a significant independent contribution by BA SI (p = 0.038, Table 5 ).
Discussion
Our primary reason for undertaking this prospective study was to investigate the relationship between posttraumatic cerebral vasospasm and clinical outcome. Previous TCD studies have failed to demonstrate a clear, independent, statistically significant association between posttraumatic cerebral vasospasm and poor outcome. 10, 12, 34, 44, 47, 50 This is partly attributable to the relatively small patient sample in most of these studies. It appears, however, that the disadvantages of the various TCD-derived diagnostic criteria have contributed to the problem. We have investigated the clinical significance of elevated flow velocity, HR, and SI. Our results clearly show that the SI, which takes into account the level of CBF, is the most clinically meaningful indicator of hemodynamically significant cerebral vasospasm. The data conclusively demonstrate a significant association between hemodynamically significant vasospasm, as defined by an elevated SI, and poor outcome in head-injured patients. Furthermore, the influence of hemodynamically significant vasospasm on outcome is independent of that of admGCS score and age. Our findings support a multimodal approach to the diagnosis of cerebral vasospasm. This approach, using concurrent TCD and CBF measurements, can better delineate outcome groups while avoiding the risks associated with angiography or the uncertainties associated with TCD monitoring alone.
Vasospasm Diagnosed by Cerebral Angiography
Cerebral angiography was the earliest technique used to diagnose vasospasm in head-injured patients. 28, 30, 48, 52 Early studies indicated an association of vasospasm with neurological deterioration 30, 52 as well as noncontusion-related infarcts. 7, 28, 30 In the largest angiographic series, Suwanwela and Suwanwela 48 reported angiographic evidence of cerebral vasospasm in 18.6% of 350 patients with head injury. This incidence of posttraumatic vasospasm is considerably lower than that reported by more recent TCD investigations. 7, 10, 33, 34, 50 The most likely reason for this discrepancy is the early time in the clinical course at which most posttraumatic angiograms were performed. Angiography is difficult to repeat due to the invasive nature of the procedure. Indeed, only 40 of the 350 patients studied by Suwanwela and Suwanwela had repeated angiograms. This is a particularly significant shortcoming because it appears that the vasospasm that follows head injury, similar to the vasospasm that follows spontaneous SAH, is a delayed phenomenon. 11, 33, 34, 44, 47, 50, 51, 53 Thus, a single, early angiogram could miss vasospasm that develops later in the clinical course.
A second disadvantage of using angiography is that only qualitative assessments can be made of the hemodynamic effects of vasospasm. Angiographic images can illustrate impaired CBF through slowing of circulation and poor filling. 28, 30, 48 Macpherson and Graham 28 demonstrated an association between ischemic brain damage in arterial territories and the combination of high-grade arterial spasm with slowing of circulation. It is not possible, however, to assess CBF quantitatively using angiography. Our results demonstrate the importance of quantitating CBF by confirming previous studies that show an important association between low CBF and poor outcome. 
Vasospasm Diagnosed by Flow Velocities Alone
Transcranial Doppler ultrasonography has proven to be a safe, noninvasive, and easily repeatable technique for detecting vasospasm of the large basal cerebral arteries. 1-3, 7,10,17,24,33,34,36,44,45,47,50 The TCD criteria used to diagnose vasospasm have undergone an evolution of sorts since the introduction of the technique. Many earlier studies simply used threshold velocities to define vasospasm. 1, 7, 10, 17, 45 In theory, however, "elevated" flow velocities can result from increased CBF and increased perfusion territory in addition to vasospasm. 46 Our own preliminary findings indicate that in the head-injured population, approximately one-fifth of observed elevated flow velocities are associated with absolute hyperemia. Previous reports have also shown "decreased" TCD flow velocities to be associated with elevated ICP, 24 hypotension, 7 and advanced age. 18 Our own TCD criteria for vasospasm require a certain threshold velocity to be reached (120 cm/second for the MCA and 90 cm/second for the BA). In our report, the significantly lower mean age of patients with TCD-diagnosed MCA vasospasm, and the trend toward lower age in patients with BA vasospasm (Table 4) probably reflect a systematic bias against elderly patients who may have vasospasm but whose TCD velocities will not reach threshold levels for diagnosis because their CBF is inherently lower. 35, 37 However, we do not ignore the possibility that younger patients may be actually more susceptible to developing vasospasm.
These issues encourage caution when interpreting the clinical significance of elevated flow velocities. Our analysis reinforces this caveat by demonstrating relatively low correlations between the highest recorded V MCA and V BA and outcome. These findings are consistent with those of Sander and Klingelhöfer, 44 who reported no significant correlation between maximum mean flow velocity and clinical outcome. The hazards associated with interpreting single-vessel flow velocities in isolation are illustrated in a previously published report. 26 In that study, the authors found little correlation between absolute V MCA and the development of neurological deficits in patients with aneurysmal SAH. These results led them to the unfortunate conclusion that the "clinical value of TCD in cases of SAH is questionable." 26 We would argue that, considered alone, the clinical significance of an elevated V MCA is indeed questionable, but that the clinical value of TCD ultrasonography greatly depends on its proper application.
Vasospasm Diagnosed by Hemispheric Ratio
In 1989, Lindegaard, et al., 27 attempted to address some of the aforementioned concerns by emphasizing the utility of an HR, defined as V MCA /V EC-ICA . Their study demonstrated a substantial agreement between a ratio measuring greater than 3 and angiographic vasospasm, with the ratio more closely correlating with angiographic findings than the absolute V MCA alone. 27 The ratio was found to be much less influenced by patient age and was presumed to help compensate for alterations in CBF, assuming a linear relationship between V EC-ICA and hemispheric CBF. Lindegaard's group reported that with marked angiographic spasm of the MCA, the V MCA was higher and the V EC-ICA lower, confirming an earlier TCD report by Aaslid, et al., 2 and indicating a measurable hemodynamic effect caused by vasospasm. As promising as these findings were, the clinical significance of an elevated HR has been difficult to define. Weber, et al., 50 found no significant difference in functional outcome between head-injured patients whose HR was greater than 3 and those whose HR did not exceed 3. Our study confirms that finding and shows no significant difference in the mean highest HR between good and poor outcome groups. Although Spearman correlation analysis does demonstrate a statistically significant correlation between the highest recorded HR and outcome, this correlation is not as high as that for lowest CBF or the SIs ( Table 2) .
The problem with the HR is that the V EC-ICA is not a dependable substitute for CBF 15-H . Although the diameter of the EC-ICA may not vary significantly in an individual with vasospasm, it clearly varies within the population depending on gender and skull width. 16 Furthermore, dayto-day EC-ICA velocity measurements are particularly influenced by differences in TCD probe position and angulation. These issues explain the difficulties in defining a clinically significant threshold for an HR within a population.
In our practice, we have used the HR only in combination with measurements of absolute V MCA to help differentiate elevated flow velocities primarily due to increased CBF from elevated velocities caused primarily by vasospasm. 33, 34 Using this definition of vasospasm, which includes both an absolute threshold V MCA and a threshold HR, we have demonstrated a significantly worse outcome in patients who develop TCD-diagnosed MCA vasospasm (Table 4 ). In the absence of available CBF measurements, we recommend this set of criteria as the most clinically meaningful, especially in the generally young head-injured population.
Elderly patients may pose a special problem because of some of the confounding issues mentioned earlier. If CBF measurements are not available in older individuals, somewhat greater emphasis may be placed on the more age-independent HR, with the important sign being a significant rise from baseline (perhaps a 100% increase) rather than the crossing of any specific threshold value.
Vasospasm Diagnosed by SI: a Multimodal Approach Using Concurrent TCD and CBF Measurements
Jakobsen, et al., 21 avoided some of the difficulties encountered using the HR by directly measuring hemispheric CBF, specifically the ISI, and using it to calculate an SI defined as V MCA /CBF ISI . Although their sample of 24 patients with spontaneous SAH was too small to draw broad conclusions, their results suggested a relationship between SI and outcome: all patients who maintained a peak SI less than 3.1 experienced a good recovery. Furthermore, the SI was found to be inversely related to CBF and directly related to AVDO 2 , suggesting that changes in the SI reflected significant hemodynamic changes. We have slightly modified the SI proposed by Jakobsen, et al., by substituting CBF 15 for the ISI. We chose the CBF 15 because it appears to be more stable than the ISI in pathological conditions with low CBF. 40 Combining TCD flow velocities with concurrent quantitative CBF measurements in an SI allows the easy identification of high flow velocities due primarily to hyper-emia rather than vasospasm (the value of the index would remain low in cases of hyperemia). Direct measurement of CBF eliminates reliance on indirect approaches for identifying hyperemia, such as monitoring for low AVDO 2 and analyzing TCD waveforms, as used in previous reports. 7, 8 Low AVDO 2 may also result from a low cerebral metabolic rate of oxygen consumption, which is quite common after head injury. 39, 42 Furthermore, AVDO 2 used alone has been found to be unreliable in estimating CBF. 43 Similarly, TCD waveform analysis has been found to be unreliable in differentiating between hyperemia and vasospasm. 25 Our study demonstrates a significantly worse outcome for head-injured patients who develop either an elevated MCA SI or an elevated BA SI, illustrating the clinical significance of these indices. We also show that patients with a high SI are twice as likely to have low CBF as those with a normal SI, indicating that an elevated SI represents vasospasm severe enough to impair CBF: hemodynamically significant cerebral vasospasm. Our findings shown in Figs. 2 and 4 (and detailed in the text) clearly imply that the factor impacting on outcome is not vasospasm per se, but hemodynamically significant vasospasm with low CBF.
It should be emphasized that an elevated SI is not always associated with low CBF. A patient can have vasospasm severe enough to affect CBF and yet maintain adequate blood flow. The patients who have hemodynamically significant cerebral vasospasm without critically low CBF are possibly the most important to identify, for although they may not yet have been injured by ischemia, they are at high risk. These patients may be the most amenable to aggressive medical therapy.
Identifying patients with vasospasm and low CBF is not easy without direct quantitative CBF measurement. A poor correlation between the level of consciousness and the level of CBF after head injury has been previously reported. 38 Furthermore, the symptoms and signs of cerebral vasospasm are not very specific, 15 and the clinical examination is complicated and insensitive to subtle changes in comatose head-injured patients. It can therefore be argued that the important and pragmatic distinction to be made in posttraumatic cerebral vasospasm is between hemodynamically significant and hemodynamically nonsignificant vasospasm, rather than between symptomatic and nonsymptomatic vasospasm.
Relative Contribution of SI, Age, and AdmGCS to Outcome
It should be emphasized that the difference in outcome between high and normal SI groups is not primarily due to differences in age or admGCS score. Advanced age has been associated with decreased baseline CBF in healthy individuals. 35, 37 It might therefore be expected that older patients would be more vulnerable to developing low CBF postinjury and suffer worse outcome. Our results tend to support this proposition (Table 4) . However, there was no significant difference in mean age between high and normal SI groups, despite the fact that those two groups had very different outcomes ( Table 4) . As for admGCS score, one would expect progressively worse outcome with lower admGCS scores, and our findings confirm this relationship (Tables 2 and 3 ). Stepwise logistic regression analysis confirms the intuitive and clinically supported notion that the severity of head injury, represented by the admGCS score, is the most important predictor of outcome (Table 5) . 31 Our results also show that high SIs exert a relatively greater influence on outcome, compared with age, in mild and moderately head injured patients, and relatively less influence in patients with more severe head injuries. This makes sense: one would expect most patients with very severe primary brain injuries to have a poor outcome regardless of whether they develop cerebral vasospasm. It is in those patients with less severe initial injuries, who might do well without secondary insults, that cerebral vasospasm has its greatest impact. To summarize, the development of hemodynamically significant cerebral vasospasm (as defined by an elevated SI) is a risk factor for poor outcome relatively independent of age and admGCS score, with its relative importance increasing with decreasing severity of head injury.
Implications for Treatment of Head-Injured Patients
The results presented here clearly show that cerebral vasospasm that occurs after traumatic brain injury, like vasospasm that occurs following aneurysmal SAH, 15 is a potentially important contributor to secondary ischemic injury. Recognition of this similarity compels one to ask whether therapies proven to be efficacious in patients with aneurysmal SAH might not also produce benefits in the head-injured population. Indeed, such a supposition has been the inspiration for recent trials investigating the utility of nimodipine in patients with traumatic brain injury. 14, 19, 23 Nimodipine has long been known to produce beneficial effects in patients with aneurysmal SAH. 5 A similar benefit has been seen in patients with posttraumatic SAH 19, 23 but not in the general head-injured population.
14 Our present report, unfortunately, cannot address the issue of whether nimodipine bestows its benefits through ameliorating effects on vasospasm or by modifying cellular metabolism (or a combination of both). Investigation of the cerebral hemodynamic effects of nimodipine and the efficacy of other therapies should prove to be fruitful areas for future study.
Confounding Issues
One potential criticism of this study is our decision not to use CBF values corrected for PCO 2 . We believe that in correlating CBF or an SI to outcome, it is important to use the actual CBF. Brain tissue is presumably indifferent to the exact cause of inadequate CBF. In addition, CO 2 reactivity has been shown to vary after head injury, with markedly diminished reactivity associated with poor outcome. 39, 41 Standard formulas used to adjust CBF values for PCO 2 may, therefore, make assumptions that simply are not true for the head-injured population.
A second criticism may center on the absence of data for AVDO 2 and cerebral metabolic rate of oxygen consumption. Measuring these parameters requires the use of jugular venous catheters. Placement of these catheters is difficult to justify in patients with a GCS score greater than 8, and difficult to continue for the 10 to 14 days necessary to include the period of spasm. A third criticism may focus on our decision not to include data on ICP, hypotension, and other factors that are associated with clinical outcome. Our research group is currently investigating many of these parameters for correlation and logistic regression analysis, and we plan to report the findings in a future article.
Conclusions
Our findings strongly support a multimodal approach to diagnosing vasospasm, which combines TCD flow velocities, and direct, quantitative CBF measurements. We have demonstrated a strong association between hemodynamically significant cerebral vasospasm, as defined by an elevated SI, and poor outcome. Early identification of patients with hemodynamically significant vasospasm could allow preemptive measures to be undertaken that may prevent critical impairment of CBF and poor outcome.
